stock.name

Acadia Pharmaceuticals Inc

ACAD

Market Cap$2.49B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Acadia Pharmaceuticals IncAcadia Pharmaceuticals Inc-14580%0%3.7-
$28.78

Target Price by Analysts

95.1% upsideAcadia Pharmaceuticals Target Price DetailsTarget Price
$18.95

Current Fair Value

28.5% upside

Undervalued by 28.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.49 Billion
Enterprise Value$2.02 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.01
Beta0.0
Outstanding Shares165,220,884
Avg 30 Day Volume1,501,097

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-1458.0
PEG1052.85
Price to Sales3.69
Price to Book Ratio7.38
Enterprise Value to Revenue2.49
Enterprise Value to EBIT-441.15
Enterprise Value to Net Income-1183
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Acadia Pharmaceuticals Inc

CEO: Uli Hacksell